Clinical Trial Update: Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase II study evaluating the bone-related effects of bortezomib in relapsed or refractory multiple myeloma; the trial was terminated with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED | Results posted: 2015-04-06